Some studies have shown that high NLR is significantly correlated with poor prognosis in triple-negative breast cancer (TNBC) but not in luminal A-like, luminal B-like, or HER2-enriched subtypes [8]. Here, ERBB2 is linked to triple-negative breast carcinoma.